Search alternatives:
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
13001
Characteristics of the respondents (n = 2,151).
Published 2024“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
-
13002
Determinants of HPV vaccine acceptance.
Published 2024“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
-
13003
-
13004
-
13005
-
13006
Blood Pressure and LDL-C During Follow-up.
Published 2025“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
-
13007
Baseline Characteristics of Included Patients.
Published 2025“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
-
13008
Predictive validity.
Published 2023“…Quantitative score normalized to baseline (w = 100% in blue). <b>A) MLI-PC feed forward inhibition</b>. The change of total activity (measured as Area Under Curve (AUC)) and the initial peak amplitude decrease exponentially with the MLI-PC strength. …”
-
13009
-
13010
Statistical summaries.
Published 2025“…This may indicate that infection causes a decrease in the effectiveness of primarily antioxidant mechanisms, whereas immune mechanisms are still activated during infection. …”
-
13011
-
13012
-
13013
-
13014
-
13015
-
13016
-
13017
-
13018
-
13019
-
13020